National and Kapodistrian University of Athens
Ανάλυση μικροβιώματος κοπράνων σε ασθενείς με λοίμωξη από Clostridioides Difficile
Abstract
dc:descriptionOBJECTIVES Clostridium difficile infection (CDI) presents with great heterogeneity whereas its final outcome cannot easily be predicted. We investigated the significance of the genetic background of the host, fecal microbiome, and Pancreatic Stone Protein (PSP) for predisposition and final outcome of CDI. METHODS The study consistied of two stages. In the first stage, DNA and serum were isolated from the peripheral blood of 134 patients with CDI and 134 controls with the same Charlson’s comorbidity index. Genome wide association study was performed using the HumanCoreExome BeadChip Kit whereas concentrations of interleukin (IL)-6, IL-8 and eotaxin were measured in serum by an enzyme immunoassay. Fecal microbiome analysis was also conducted. Single nucleotide polymorphisms (SNPs) that can be included in a genetic score for CDI predisposition were depicted after step-wise logistic regression analysis. Clinical data, measured cytokines and SNPs and fecal bacterial species different among patients with favorable and unfavorable outcome were included in a prognostic score. In the second stage, PSP levels were measured in patients with CDI from 13 hospitals across Greece. Unfavorable outcome was defined as the progression into organ dysfunction or/and relapse after treatment and/or death. RESULTS During the first stage, 17 SNPs were associated with CDI fourteen of which ((rs12148744, rs714024, rs721059, rs4311028, rs62183547, rs1128266, rs4279595, rs175006, rs3859214, rs7222870, rs5086600, rs7240534, rs20911172, rs17680671) were included in the genetic score; values greater than 10 provided >80% positive predictive value (PPV) for CDI. Hemoglobin lower than 9.5 g/dl, urea greater than 64.5 mg/dl, IL-8 greater than 227 pg/ml and the presence of one G allele of rs2091172 and the presence of Terrisporobacter glycolycus, Enterococcus avium, or Anaerovax odorimutans in stool were included in the prognosis score, which demonstrated a sensitivity of 84.6% and a specificity of 95.8% for early prediction of unfavorable outcome. In the secod stage, 147 patients were analyzed, of whom 57 experienced unfavorable outcome. PSP levels were significantly higher in these patients, with an area under the curve (AUC) of 0.648 (95% confidence interval (CI) 0.550-0.746, p: 0.003) for predicting unfavorable outcome. The optima cut-off value was 300 ng/mL, which was associated with a significantly increased risk (odds ratio (OR) 3.73, 95% CI 1.822-7.638, p < 0.00001). The combination of elevated PSP and C-reactive protein (CRP) provided stronger prognostic value (OR 7.04, 95% CI 2.78-17.85, p < 0.001). In multivariable analysis, PSP ≥300 ng/mL (p: 0.006) and CRP ≥90 mg/L (p: 0.04) remained independent risk factors for unfavorable outcome. CONCLUSIONS A personalized score for the outcome of CDI is described for the first time, as well as the evaluation of PSP in patients with CDI. The score and PSP – particularly when combined with CRP - may guide treatment decision-making.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tziolos, Renatos
- Τζιώλος, Ρενάτος
Subjects
dc:subject × 18- Clostridioides difficile
- Μονήρεις νουκλεοτιδικοί πολυμορφισμοί
- Μικροβίωμα
- Pancreatic Stone Protein
- Δυσμενής έκβαση
- Single nucleotide polymorhisms
- Microbiome
- Adverse outcomes
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Κλινική Ιατρική
- Γενική και Εσωτερική ιατρική
- Health Sciences
- Medical and Health Sciences
- Infectious Diseases
- Clinical Medicine
- General and Internal Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61033